Influence of platelet size before coronary angioplasty on subsequent restenosis

European Journal of Clinical Investigation

Volumn 23, Issue 6, 1993, Pages 361-367

  SMYTH, D W ^a   MARTIN, J F ^b   MICHALIS, L ^a   BUCKNALL, C A ^a   JEWITT, D E ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary angioplasty; platelet size; restenosis.

Indexed keywords

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DILATATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTE SHAPE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PLATELETS; CELL SIZE; CORONARY DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; RECURRENCE; REOPERATION;

EID: 0027175785     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.1993.tb02037.x     Document Type: Article

References (42)

1. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.
2. Restenosis after successful coronary angioplasty in patients with single vessel disease.
3. Incidence of restenosis after successful coronary angioplasty: A time related phenomenon: A quantitative angiographic follow up study in 342 patients at 1, 2, 3 and 4 months.
4. Restenosis after percutaneous transluminal coronary angioplasty
5. Recurrence rate after successful coronary angioplasty
6. Restenosis after successful percutaneous coronary angioplasty: serial angiographic follow up of 299 patients.
7. “Crackers, breakers, stretchers, drillers, shavers, scrapers, burners, welders, melters”—the future treatment of atherosclerotic coronary artery disease?. A clinico‐morphologic assessment
8. A paradigm for restenosis based on cell biology: clues for the development of new preventative strategies
9. Restenosis after Coronary Angioplasty. Potential biologic determinants and role of intimal hyperplasia
10. Restenosis after arterial angioplasty: A hemorrheologic response to injury
11. Balloon angioplasty: natural history of pathophysiological response to injury in a pig model.
12. Transluminal coronary angioplasty and early restenosis: fibrocellular occlusion after wall laceration
13. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty
14. Restenosis after percutaneous transluminal angioplasty: Pathologic observations in 20 patients.
15. Primary peripheral arterial stenoses and restenoses excised by transluminal atherectomy: a histopathological study
16. The pathogenesis of atherosclerosis—An update
17. Platelet Accumulation in experimental angioplasty: time course and relation to vascular injury
18. 111indium‐labelled platelet scintigram, quantitative platelet deposition and mural thrombosis.
19. Vascular permeation of platelet factor 4 after endothelial injury
20. Identification of mRNA for PDGF in human megakaryocytes using a novel immunomagnetic separation method
21. Measurement of the density of human platelets and relationship to volume
22. Platelet density and size: the interpretation of heterogeneity
23. The relationship between platelets and megakaryocyte volumes
24. Accelerated atherogenesis occurs following platelet destruction and increases in megakaryocyte size and DNA content
25. Serrys PW et al. Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavourable early and late outcome
26. Restenosis: The Clinical Issues.
27. Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocar‐dial infarction and unstable angina pectoris
28. The biological significance of platelet volume; its relation to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration
29. Change in volume and density of platelets in myocardial infarction
30. The Heterogeneity of platelets.
31. The effects of thrombocytopenia on experimental atherosclerotic lesion formation in rabbit.
32. Role of platelets in smooth muscle cell and migration after vascular injury in rat carotid artery
33. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF
34. Production of platelet‐derived growth factor‐like mitogen by smooth muscle cells from human atheroma
35. Cellular transformation by coordinate action of three peptide growth factors from human platelets
36. Influence of platelet size on outcome after myocardial infarction
37. Aspirin and Dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
38. Neither ticlopidine nor aspirin‐dipyridamole prevents restenosis post PTCA: results from a randomized placebo‐controlled multicenter trial.
39. Randomized trial of fish oil for the prevention of restenosis after coronary angioplasty.
40. Determinants of restenosis and lack of effect of dietary supplementation with eicosapentanoic acid on the incidence of coronary artery restenosis after angioplasty.
41. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n‐3 fatty acids.
42. The control of megakaryocyte ploidy and platelet production: Biology and Pathology